Infectious Agents and Cancer (Record no. 189910)

MARC details
000 -LEADER
fixed length control field 03757nas a22003615i 4500
001 - CONTROL NUMBER
control field 1750-9378
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20180511105628.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||xxkuu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1750-9378
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 13027
Source of number or code local
210 10 - ABBREVIATED TITLE
Abbreviated title Infect Agents Cancer
245 10 - TITLE STATEMENT
Title Infectious Agents and Cancer
Medium [electronic resource] /
Statement of responsibility, etc. edited by Franco M. Buonaguro, Sam M. Mbulaiteye, Maria Lina Tornesello.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture London :
Name of producer, publisher, distributor, manufacturer BioMed Central :
-- Imprint: BioMed Central.
300 ## - PHYSICAL DESCRIPTION
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer. The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular: • HPV and anogenital cancers, as well as head and neck cancers; • EBV and Burkitt lymphoma; • HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases; • HHV8 and Kaposi sarcoma; • HTLV and leukemia; • Cancers in Low- and Middle-income countries. The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries. Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies. Moreover “omics” is contributing to and accelerating the discovery not only of novel pathogens, but of genetic predisposition as the genetic make-up of organisms and individuals is unraveled. The hunt for molecular signatures of cancer causation, early cancer, or cancer Achilles heels promises new ways to practice precision medicine and public health. The explosion of knowledge in tumor genomics, tumor biology, targeted therapies, gene-environment interactions, immunology and immunotherapy needs a space for robust and vigorous debate. Infectious Agents and Cancer covers all these areas of biomedical research and any other topics pertinent to the development of preventive strategies, innovative diagnostic and biomolecular methodologies, promising therapeutic strategies for chronic infections and cancer. Immunotherapeutic strategies will include: profiling and activation of dendritic cells; reactivation of the immune system; breaking immune tolerance; modulation of the immune system by cytokines and drug delivery systems.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infectious diseases.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tropical medicine.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Research.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infectious Diseases.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tropical Medicine.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Buonaguro, Franco M.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mbulaiteye, Sam M.
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tornesello, Maria Lina.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://link.springer.com/journal/13027">http://link.springer.com/journal/13027</a>
Public note Open Access

No items available.